Restricted accessResearch articleFirst published online 2017-05
An Effective Method of Atelocollagen Type 1/3 Isolation from Human Placenta and Its In Vitro Characterization in Two-Dimensional and Three-Dimensional Cell Culture Applications
Pepsin-solubilized atelocollagen can be used to form highly complex three-dimensional matrices for a broad spectrum of tissue engineering applications. Moreover, it has a long history as a favorable biomaterial in pharmaceutical and medical industries. So far, the main sources for these approaches are collagens from xenogenic sources. Yet, these nonhuman collagens carry a risk of provoking immune reactions in patients.
Here we describe an effective method of isolating atelocollagen type 1/3 (COL1/3) from human placenta. By combining a single pepsin digestion step with tangential flow filtration and further precipitation steps, we could purify COL1/3 within only 4 days of processing. The resulting COL1/3 was biochemically characterized by determining residual DNA content, proving the absence of impurities by sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) analysis combined with total amino acid quantification, identifying the isolated collagen types by Western blot analysis, and analyzing the spontaneous formation of fibrous structures on freeze-drying via scanning electron microscopy. Finally, the cytocompatibility of the isolated collagen was demonstrated in two dimensional using primary rat hepatocytes and in three dimensional by a sprouting assay of human umbilical vein endothelial cell. The isolation method described not only fulfills demands for cost-efficient bioengineering using a human waste material but also potentially increases overall safety for patients by use of homologous products.
Get full access to this article
View all access options for this article.
References
1.
Parenteau-BareilR., GauvinR., and BerthodF.Collagen-based biomaterials for tissue engineering applications. Materials (Basel), 3, 1863, 2010.
2.
AbrahamL.C., ZuenaE., Perez-RamirezB., and KaplanD.L.Guide to collagen characterization for biomaterial studies. J Biomed Mater Res Part B Appl Biomater, 87, 264, 2008.
3.
LinS., and GuL.Influence of crosslink density and stiffness on mechanical properties of type I collagen gel. Materials (Basel), 8, 551, 2010.
4.
MiyataT., TairaT., and NoishikiY.Collagen engineering for biomaterial use. Clin Mater, 9, 139, 1992.
KishimotoY., HiranoS., KojimaT., KanemaruS.I., and ItoJ.Implantation of an atelocollagen sheet for the treatment of vocal fold scarring and sulcus vocalis. Ann Otol Rhinol Laryngol, 118, 613, 2009.
7.
EaglsteinW.H., et al.Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatologic Surg, 25, 195, 1999.
8.
JanssonK., HaegerstrandA., and KrtazG.A biodegradable bovine collagen membrane as a dermal template for human in vivo wound healing. Scand J Plast Reconstr Hand Surg, 35, 369, 2001.
9.
GroeberF., HoleiterM., HampelM., HindererS., and Schenke-LaylandK.Skin tissue engineering—in vivo and in vitro applications. Adv Drug Deliv Rev, 63, 352, 2011.
10.
FlynnL., HrabchakC., and WoodhouseK.A.Biological skin substitutes for wound cover and closure. Expert Rev Med Devices, 3, 1, 2006.
11.
PlaceE.S., EvansN.D., and StevensM.M.Complexity in biomaterials for tissue engineering. Nat Mater, 8, 457, 2009.
12.
SclafaniA.P.Autologous collagen dispersion (Autologen) as a dermal filler. Arch Facial Plast Surg, 2, 48, 2000.
13.
BaumannL., KaufmannJ., and SaghariS.Collagen fillers. Dermatol Ther, 19, 134, 2006.
14.
RequenaL., et al.Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol, 64, 1, 2011.
15.
LynnA.K., YannasI.V., and BonfieldW.Antigenicity and immunogenicity of collagen. J Biomed Mater Res Part B Appl Biomater, 71, 343, 2004.
16.
MagarianEM.Safety of intra-articular use of atelocollagen for enhanced tissue repair. Open Orthop J, 6, 231, 2012.
17.
KimB.S., et al.Human collagen isolated from adipose tissue. Biotechnol Prog, 28, 973, 2012.
18.
PacakC.A., MacKayA., and CowanD.B.An improved method for the preparation of type I collagen from skin. J Vis Exp, 83, e51011, 2014.
19.
BrowneS., ZeugolisD.I., and PanditA.Collagen: finding a solution for the source. Tissue Eng Part A, 19, 1491, 2013.
20.
HamiltonB.E., MartinJ.A., OstermanM.J.K., CurtinS.C., and MatthewsT.J.Births: final data for 2013. Natl Vital Stat Rep, 64, 1, 2015.
YoshizawaR.S.Review: public perspectives on the utilization of human placentas in scientific research and medicine. Placenta, 34, 9, 2013.
23.
NiyibizisC., FietzeksP.P., and RestsllM.Van Der. Human placenta type V collagens. J Biol Chem, 2, 14170, 1984.
24.
KlassonS.C., KleinL.N., DimariS.J., and HaralsonM.A.The effects of tissue pretreatment and pepsin levels on the isolation of collagens from human placenta. Coll Relat Res, 6, 397, 1986.
25.
SchneiderK.H., et al.Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts. Acta Biomater, 29, 125, 2016.
26.
WeihsA.M., et al.Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation. J Biol Chem, 289, 27090, 2014.
27.
DuhamelR.C.Differential staining of collagens and non-collagens with Coomassie Brilliant Blue G and R. Coll Relat Res, 3, 195, 1983.
28.
ShenL., HillebrandA., WangD.Q.-H., and LiuM.Isolation and primary culture of rat hepatic cells. J Vis Exp, 1, 2012. doi:10.3791/3917
29.
FengZ.Q., et al.Rat hepatocyte aggregate formation on discrete aligned nanofibers of type-I collagen-coated poly(l-lactic acid). Biomaterials, 31, 3604, 2010.
30.
SchuhC.M.A.P., et al. Activated schwann cell-like cells on aligned fibrin-poly(lactic-co-glycolic acid) structures: a novel construct for application in peripheral nerve regeneration. Cells Tissues Organs, 200, 287, 2015.
31.
RohringerS., et al.Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells. Angiogenesis, 17, 921, 2014.
32.
TestoriJ., et al.The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells. Blood, 117, 2735, 2011.
33.
SageH.Structural studies on human type IV Structural Studies on Human Type IV Collagen. J Biol Chem, 254, 9893, 1979.
34.
MacWrightR.S., BensonV.A., LovelloK.T., van der RestM., and FietzekP.P.Isolation and characterization of pepsin-solubilized human basement membrane (type IV) collagen peptides. Biochemistry, 22, 4940, 1983.
35.
SellS., and LiicZ.Liver stem cells. Germany: Springer, 1997, ISBN: 3-540-61427-3.
36.
KorffT., and AugustinH.G.Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci, 112, 3249, 1999.
37.
DewittD.D., KaszubaS.N., ThompsonD.M., and StegemannJ.P.Collagen I-matrigel scaffolds for enhanced Schwann cell survival and control of three-dimensional cell morphology. Tissue Eng Part A, 15, 2785, 2009.
38.
LiuT., HouleJ.D., XuJ., ChanB.P., and ChewS.Y.Nanofibrous collagen nerve conduits for spinal cord repair. Tissue Eng Part A, 18, 1057, 2012.
39.
TutroneWD, and CohenJL. Dissolving collagen fillers: enzymatic degradation of some problematic filler circumstances may not include collagens. J Drugs Dermatol, 8, 1140, 2009.
40.
DeLustroF., DaschJ., KeefeJ., and EllingsworthL.Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop Relat Res. 263, 1990.
41.
AlsterT.S., and WestT.B.Human-derived and new synthetic injectable materials for soft-tissue augmentation: current status and role in cosmetic surgery. Plast Reconstr Surg, 105, 2515, 2000.
42.
SclafaniA.P., et al.Homologous collagen dispersion (dermalogen) as a dermal filler: persistence and histology compared with bovine collagen. Ann Plast Surg, 49, 181, 2002.
43.
BaumannL.Collagen-containing fillers: alone and in combination. Clin Plast Surg, 33, 587, 2006.
44.
PacakC.A., PowersJ.M., and CowanD.B.Ultrarapid purification of collagen type I for tissue engineering applications. Tissue Eng Part C Methods, 17, 879, 2011.
45.
ŞakrakT., et al.The effects of combined application of autogenous fibroblast cell culture and full-tissue skin graft (FTSG) on wound healing and contraction in full-thickness tissue defects. Burns, 38, 225, 2012.
46.
SteinH., et al.Production of bioactive, post-translationally modified, heterotrimeric, human recombinant type-I collagen in transgenic tobacco. Biomacromolecules, 10, 2640, 2009.
47.
BrodskyB., and KaplanD.L.Shining light on collagen: expressing collagen in plants. Tissue Eng Part A, 19, 1499, 2013.
48.
ShoseyovO., PosenY., and GrynspanF.Human recombinant type I collagen produced in plants. Tissue Eng Part A, 19, 1527, 2013.
49.
LindenmairA., and HatlapatkaT.Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells, 1, 1061, 2012.
50.
LindenmairA., andWolbankS., et al. Osteogenic differentiation of intact human amniotic membrane. Biomaterials, 31, 8659, 2011.
51.
CaiJ., LiW., SuH., et al.Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem, 285, 11227, 2010.
52.
BanerjeeA., et al.In toto differentiation of human amniotic membrane toward the Schwann cell lineage. Cell Tissue Bank, 15, 227, 2014.
53.
MyersJ.C., et al.Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini. J Biol Chem, 278, 32047, 2003.
54.
KanayamaN., TeraoT., KawashimaY., HoriuchiK., and FujimotoD.Collagen types in normal and prematurely ruptured amniotic membranes. Am J Obstet Gynecol, 153, 899, 1985.
55.
GuptaA., KedigeS.D., and JainK.Amnion and chorion membranes: potential stem cell reservoir with wide applications in periodontics. Int J Biomater, 15, 983, 2015.
56.
LoboS.E., et al.The placenta as an organ and a source of stem cells and extracellular matrix: a review. Cells Tissues Organs, 201, 239, 2016.
57.
SerenaT.E., et al.A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers. Wound Repair Regen, 22, 668, 2014.
58.
ZelenC.M., SerenaT.E., and FetterolfD.E.Dehydrated human amnion/chorion membrane allografts in patients with chronic diabetic foot ulcers: a long-term follow-up study. Wound Med, 4, 1, 2014.
59.
ChakrabortyP.D., and BhattacharyyaD.Isolation of fibronectin type III like peptide from human placental extract used as wound healer. J Chromatogr B Anal Technol Biomed Life Sci, 818, 67, 2005.
60.
HongJ.W., LeeW.J., HahnS.B., KimB.J., and LewD.H.The effect of human placenta extract in a wound healing model. Ann Plast Surg, 65, 96, 2010.
61.
OhE.J., KimT.K., ShinJ.H., ChoiJ.H., and ChungH.Y.Biologic filler using human fibroblasts and placenta extracts. J Craniofac Surg, 22, 1557, 2011.
62.
ChakrabortyP.D., DeD., BandyopadhyayS., and BhattacharyyaD.Human aqueous placental extract as a wound healer. J Wound Care, 18, 462, 464, 2009.
63.
BurgosH., HerdA., and BennettJ.P.Placental angiogenic and growth factors in the treatment of chronic varicose ulcers: preliminary communication. J R Soc Med, 82, 598, 1989.
64.
ShuklaV.K., RasheedM.A., KumarM., GuptaS.K., and PandeyS.S.A trial to determine the role of placental extract in the treatment of chronic non-healing wounds. J Wound Care, 13, 177, 2004.
65.
NavadiyaS.K., VaghaniY.L., and PatelM.P.Study of topical placental Extract versus povodine iodine and saline dressing in various diabetic wounds. Natl J Med Res, 2, 411, 2012.
66.
TomanP.D., EgbertB.M., ThomasJ.A., and DeLustroF.A.Development of a novel nonantigenic dermal implant composed of human placental collagen. Plast Reconstr Surg, 113, 1015, 2004.
67.
GlanvilleR.W., RauterA., and FietzekP.P.Isolation and characterization of a native placental basement-membrane collagen and its component alpha chains. Eur J Biochem, 95, 383, 1979.
68.
KresinaT.F., and MillerE.J.Isolation and characterization of basement membrane collagen from human placental tissue. Evidence for the presence of two genetically distinct collagen chains. Biochemistry, 18, 3089, 1979.
69.
QuteishD., SinghG., and DolbyA.E.Development and testing of a human collagen graft material. J Biomed Mater Res, 24, 749, 1990.
70.
BrownC.Structure and binding properties of collagen type XIV isolated from human placenta. J Cell Biol, 120, 557, 1993.
71.
MocanE., TagadiucO., and NacuV.Aspects of collagen isolation procedure. Clin Res Stud, 8, 320, 2011.
72.
WuX., et al.Comparative study on acid-soluble and pepsin-soluble collagens from skin and swim bladder of grass carp (Ctenopharyngodon idella). J Sci Food Agric, 96, 815, 2016.
73.
YuD., ChiC.F., WangB., DingG.F., and LiZ.R.Characterization of acid-and pepsin-soluble collagens from spines and skulls of skipjack tuna (Katsuwonus pelamis). Chin J Nat Med, 12, 712, 2014.
74.
ZhangY., et al.Mechanism of extraordinary DNA digestion by pepsin. Biochem Biophys Res Commun, 472, 101, 2016.
75.
QianJ., et al.Kinetic analysis of the digestion of bovine type I collagen telopeptides with porcine pepsin. J Food Sci, 81, C27, 2016.
76.
CoxM.M., NelsonD.L., and LehningerA.L.Principles of biochemistry, 5th ed. San Francisco: W.H. Freeman, 2008.
77.
DelgadoL.M., BayonY., PanditA., and ZeugolisD.I.To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices. Tissue Eng Part B Rev, 21, 298, 2015.
78.
HsuH.-T., et al.External vibration enhances macromolecular crowding for construction of aligned three-dimensional collagen fibril scaffolds. Biofabrication, 7, 1025, 2015.
79.
GreetjeE., et al.Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab, 7, 629, 2006.
80.
KimY., LasherC.D., MilfordL.M., MuraliT.M., and RajagopalanP.A comparative study of genome-wide transcriptional profiles of primary hepatocytes in collagen sandwich and monolayer cultures. Tissue Eng Part C Methods, 16, 1449, 2010.
81.
ZhaoY., et al.In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng Part C Methods, 16, 653, 2010.
82.
ChanB.P., et al.Self-assembled collagen-human mesenchymal stem cell microspheres for regenerative medicine. Biomaterials, 28, 4652, 2007.
83.
NatesanS., BaerD.G., WaltersT.J., BabuM., and ChristyR.J.Adipose-derived stem cell delivery into collagen gels using chitosan microspheres. Tissue Eng Part A, 16, 1369, 2010.
84.
FernandesH., et al.Endogenous collagen influences differentiation. Tissue Eng Part A, 16, 1693, 2010.
85.
PedrazaC.E., MarelliB., ChicatunF., McKeeM.D., and NazhatS.N.An in vitro assessment of a cell-containing collagenous extracellular matrix-like scaffold for bone tissue engineering. Tissue Eng Part A, 16, 781, 2010.
86.
AhnS., et al.Designed three-dimensional collagen scaffolds. Tissue Eng Part C Methods, 16, 813, 2010.
87.
CrossV.L., et al.Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials, 31, 8596, 2010.
88.
SollerE.C., TzeranisD.S., MiuK., SoP.T.C., and YannasI.V.Common features of optimal collagen scaffolds that disrupt wound contraction and enhance regeneration both in peripheral nerves and in skin. Biomaterials, 33, 4783, 2012.
89.
BreyE.M., UrielS., GreislerH.P., and McIntireL.V.Therapeutic Neovascularization: contributions from Bioengineering. Tissue Eng, 11, 567, 2005.
90.
GérardC., BordeleauL.J., BarraletJ., and DoillonC.J.The stimulation of angiogenesis and collagen deposition by copper. Biomaterials, 31, 824, 2010.
91.
DengC., et al.A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A, 16, 3099, 2010.
92.
DaamenW.F., et al.A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation without calcification. Tissue Eng Part A, 14, 349, 2008.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
